Cosmo Pharmaceuticals Launches Winlevi® in Singapore and Malaysia, Expanding Acne Treatment in Southeast Asia
I'm PortAI, I can summarize articles.
Cosmo Pharmaceuticals N.V. has launched Winlevi® (clascoterone) cream 1% in Singapore and Malaysia, partnering with Hyphens Pharma International Limited. This acne treatment targets patients aged twelve and older and is part of Cosmo's strategy to expand its global presence in response to rising demand for advanced acne care in Southeast Asia. The launch aims to provide innovative dermatology solutions and enhance the quality of life for those affected by acne.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments